Tocilizumab Does Not Improve Outcomes in Severe COVID-19
Tocilizumab plus standard care no better for improving clinical outcomes at 15 days and may increase mortality
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.